Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Vertex Pharmaceuticals Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

55 comunicati stampa

Guarda tutti i comunicati
20/01/2026
Scienza
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Biotecnologia
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
11/01/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
22/12/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/12/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
19/11/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
08/11/2025
Eventi
Industria
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
03/11/2025
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Vertex Reports Third Quarter 2025 Financial Results
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
27/10/2025
Eventi
Web e Social Network
Biotecnologia
Salute
Scienza
Farmaceutica
Vertex to Participate in the UBS Global Healthcare Conference on November 11
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
23/10/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Eventi
Industria
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
17/10/2025
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Industria
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0